If hypofractionated radiation with curative
intent can reduce the
treatment time for lung cancer patients by half with no greater toxicity, and with equivalent — if not better — tumor control and survival outcomes, this research could result
in a
change in the paradigm of how a large subset of locally advanced NSCLC patients are treated.»